These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 32643821)
1. High low-density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions. Hasegawa S; Nakano T; Mukai Y; Matsukuma Y; Yotsueda R; Tsuchimoto A; Fujisaki K; Tsuruya K; Tsutsui H; Kitazono T Ther Apher Dial; 2021 Jun; 25(3):296-303. PubMed ID: 32643821 [TBL] [Abstract][Full Text] [Related]
2. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry. Nagata I; Ike A; Nishikawa H; Zhang B; Sugihara M; Mori K; Iwata A; Kawamura A; Shirai K; Uehara Y; Ogawa M; Miura S; Saku K J Cardiol; 2015 Feb; 65(2):105-11. PubMed ID: 24997801 [TBL] [Abstract][Full Text] [Related]
3. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis. Endo A; Yoshida Y; Kageshima K; Sato H; Suga T; Nasu H; Takahashi N; Tanabe K Intern Med; 2014; 53(8):819-28. PubMed ID: 24739601 [TBL] [Abstract][Full Text] [Related]
4. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study. Ren X; Wang X Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911 [TBL] [Abstract][Full Text] [Related]
5. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention. Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660 [TBL] [Abstract][Full Text] [Related]
6. [Different effects of inflammation and lipid levels on coronary lesions after PCI]. Xu HY; Qiao SB; Li JJ; Yang YJ; Zhang JF; Xu B; Xie GQ; Dong QT Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2249-52. PubMed ID: 20095335 [TBL] [Abstract][Full Text] [Related]
7. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL. Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009 [TBL] [Abstract][Full Text] [Related]
9. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Matsumoto I; Miyake Y; Mizukawa M; Takagi Y Circ J; 2011; 75(4):905-10. PubMed ID: 21325724 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome. Kidawa M; Gluba-Brzózka A; Zielinska M; Franczyk B; Banach M; Rysz J Curr Vasc Pharmacol; 2019; 17(4):365-375. PubMed ID: 29852873 [TBL] [Abstract][Full Text] [Related]
11. Impact of chronic kidney disease on a re-percutaneous coronary intervention for sirolimus-eluting stent restenosis. Aoyama Y; Hirayama H; Ishii H; Kobayashi K; Ishikawa K; Takigawa M; Nanasato M; Yoshida Y; Aoyama T; Yoshikawa D; Matsubara T; Murohara T Coron Artery Dis; 2012 Dec; 23(8):528-32. PubMed ID: 22975841 [TBL] [Abstract][Full Text] [Related]
12. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry. Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396 [TBL] [Abstract][Full Text] [Related]
13. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Zhang J; He L BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772 [TBL] [Abstract][Full Text] [Related]
14. Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry. Shiiba M; Zhang B; Miura SI; Ike A; Nose D; Kuwano T; Imaizumi S; Sugihara M; Iwata A; Nishikawa H; Kawamura A; Shirai K; Yasunaga S; Saku K Heart Vessels; 2018 Feb; 33(2):102-112. PubMed ID: 28815384 [TBL] [Abstract][Full Text] [Related]
15. Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation. Zhao J; Wang X; Wang H; Zhao Y; Fu X Ir J Med Sci; 2020 Aug; 189(3):907-915. PubMed ID: 31989420 [TBL] [Abstract][Full Text] [Related]
16. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention. Sud M; Han L; Koh M; Abdel-Qadir H; Austin PC; Farkouh ME; Godoy LC; Lawler PR; Udell JA; Wijeysundera HC; Ko DT J Am Coll Cardiol; 2020 Sep; 76(12):1440-1450. PubMed ID: 32943162 [TBL] [Abstract][Full Text] [Related]
17. Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation. Imaizumi S; Miura S; Takata K; Takamiya Y; Kuwano T; Sugihara M; Ike A; Iwata A; Nishikawa H; Saku K Heart Vessels; 2016 Aug; 31(8):1257-65. PubMed ID: 26337618 [TBL] [Abstract][Full Text] [Related]
18. [Low-density lipoprotein cholesterol target goal attainment rate and related factors in patients with acute coronary syndrome after percutaneous coronary intervention]. Zhang B; Dong X; Zhang Y; Huang R; Yin D; Zheng Z; Liu Y; Zhu H; Zhou X Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):290-4. PubMed ID: 24924454 [TBL] [Abstract][Full Text] [Related]
19. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol. Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028 [TBL] [Abstract][Full Text] [Related]
20. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level. Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]